Chinese Version of the Psychological Inflexibility in Pain Scale for Cancer Patients Reporting Chronic Pain.
Chan-Juan Xie, Xiang-Hua Xu, Mei-Jun Ou and 1 others
PMID 31651462WHAT IT FOUND
A Chinese questionnaire for pain-related avoidance and cognitive fusion appears usable for Chinese cancer patients with chronic pain.
Scores were stable over 14 days and items separated high and low scorers; no clinical cutoff is available.
Key findings
01In 359 analysed patients with cancer pain, the Chinese PIPS kept its two-part structure of avoidance and cognitive fusion.
02The total score was internally consistent (.87), as were avoidance (.88) and cognitive fusion (.74).
03In 120 patients retested after 14 days, scores were highly stable: overall .98, avoidance .98, and cognitive fusion .97.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The scale was tested only in Chinese-speaking cancer patients with pain lasting more than 3 months and pain intensity at least 4, so it may not apply to other languages, pain levels, or shorter pain histories. Patients were excluded if they had neurological, psychiatric, or cognitive disorders or were receiving psychotherapy, so results do not cover those groups. The sample came from one hospital and included many cancer types, so performance may differ by cancer type or setting. No clinical cutoff was established, so a score cannot yet be used to define a clear threshold for action. The study tested measurement properties, not whether using the PIPS changes care or patient outcomes. Test-retest stability was checked in 120 patients, not all 359.
Declared interests
The authors declared no conflicts of interest.
The easy way to misread this
Do not treat this scale as proven to guide cancer pain care or to set a cutoff. It shows the Chinese version measures avoidance and cognitive fusion in these patients, but no treatment effect or clinical threshold was tested.